Cargando…
Identification and Validation of Novel PERK Inhibitors
[Image: see text] PERK, as one of the principle unfolded protein response signal transducers, is believed to be associated with many human diseases, such as cancer and type-II diabetes. There has been increasing effort to discover potent PERK inhibitors due to its potential therapeutic interest. In...
Autores principales: | Wang, Qiantao, Park, Jihyun, Devkota, Ashwini K., Cho, Eun Jeong, Dalby, Kevin N., Ren, Pengyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038368/ https://www.ncbi.nlm.nih.gov/pubmed/24745945 http://dx.doi.org/10.1021/ci500114r |
Ejemplares similares
-
Using docking and alchemical free energy approach to determine the binding mechanism of eEF2K inhibitors and prioritizing the compound synthesis
por: Wang, Qiantao, et al.
Publicado: (2015) -
Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA−/lo castration-resistant cells
por: Rycaj, Kiera, et al.
Publicado: (2016) -
Modeling
Organochlorine Compounds and the σ-Hole
Effect Using a Polarizable Multipole Force Field
por: Mu, Xiaojiao, et al.
Publicado: (2014) -
Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors
por: Stokes, Michael E., et al.
Publicado: (2022) -
Glycosylation PERKs
por: Williams, Ruth
Publicado: (2007)